This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...